Roche sees Carmot obesity drugs' potential peak sales at $3.6B+: report
The three candidates were identified as CT-388, CT-996 and CT-868 ... (VKTX), Altimmune (ALT), Zealand Pharma ...
Hosted on MSN5mon
Roche Setback Is Big for Eli Lilly, Novo Nordisk Stock as Obesity Drug Battle Ramps Up
On Thursday, Roche’s American depositary receipts rose 2.6% to $38.30. The once-daily pill, called CT-996, helps control blood sugar levels and is being developed to treat diabetes and obesity.